Is Omnicell (OMCL) Stock Undervalued Right Now?

07.10.25 15:40 Uhr

Werte in diesem Artikel
Aktien

25,80 EUR -16,60 EUR -39,15%

Indizes

22.788,4 PKT -153,3 PKT -0,67%

The proven Zacks Rank system focuses on earnings estimates and estimate revisions to find winning stocks. Nevertheless, we know that our readers all have their own perspectives, so we are always looking at the latest trends in value, growth, and momentum to find strong picks.Looking at the history of these trends, perhaps none is more beloved than value investing. This strategy simply looks to identify companies that are being undervalued by the broader market. Value investors use a variety of methods, including tried-and-true valuation metrics, to find these stocks.Luckily, Zacks has developed its own Style Scores system in an effort to find stocks with specific traits. Value investors will be interested in the system's "Value" category. Stocks with both "A" grades in the Value category and high Zacks Ranks are among the strongest value stocks on the market right now.One stock to keep an eye on is Omnicell (OMCL). OMCL is currently holding a Zacks Rank #2 (Buy) and a Value grade of A. Investors should also note that OMCL holds a PEG ratio of 3.07. This popular figure is similar to the widely-used P/E ratio, but the PEG ratio also considers a company's expected EPS growth rate. OMCL's PEG compares to its industry's average PEG of 8.51. Over the past 52 weeks, OMCL's PEG has been as high as 24.94 and as low as 2.78, with a median of 4.59.Value investors also use the P/S ratio. The P/S ratio is calculated as price divided by sales. This is a preferred metric because revenue can't really be manipulated, so sales are often a truer performance indicator. OMCL has a P/S ratio of 1.22. This compares to its industry's average P/S of 2.43.These figures are just a handful of the metrics value investors tend to look at, but they help show that Omnicell is likely being undervalued right now. Considering this, as well as the strength of its earnings outlook, OMCL feels like a great value stock at the moment.5 Stocks Set to DoubleEach was handpicked by a Zacks expert as the #1 favorite stock to gain +100% or more in the coming year. While not all picks can be winners, previous recommendations have soared +112%, +171%, +209% and +232%.Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.Today, See These 5 Potential Home Runs >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Omnicell, Inc. (OMCL): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

In eigener Sache

Übrigens: Omnicell und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und Neukunden-Bonus sichern!

Ausgewählte Hebelprodukte auf Omnicell

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Omnicell

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu Omnicell Inc.

Wer­bung

Analysen zu Omnicell Inc.

DatumRatingAnalyst
26.07.2019Omnicell BuyCraig Hallum
07.03.2019Omnicell BuyDougherty & Company LLC
29.06.2018Omnicell BuyThe Benchmark Company
05.09.2017Omnicell BuyThe Benchmark Company
28.07.2017Omnicell BuyDougherty & Company LLC
DatumRatingAnalyst
26.07.2019Omnicell BuyCraig Hallum
07.03.2019Omnicell BuyDougherty & Company LLC
29.06.2018Omnicell BuyThe Benchmark Company
05.09.2017Omnicell BuyThe Benchmark Company
28.07.2017Omnicell BuyDougherty & Company LLC
DatumRatingAnalyst
06.03.2009Omnicell holdBB&T Capital Markets
19.12.2008Omnicell averageCaris & Company, Inc.
11.06.2008Omnicell above averageCaris & Company, Inc.
01.02.2008Omnicell averageCaris & Company, Inc.
05.12.2007Omnicell averageCaris & Company, Inc.
DatumRatingAnalyst
22.01.2009Omnicell DowngradeBB&T Capital Markets

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Omnicell Inc. nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen